Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J has tough third quarter

Executive Summary

Firm's U.S. skin-care business declined 15.9% on an operational basis and oral care fell 12.3% over a "disappointing" third quarter, Johnson & Johnson announces Oct. 19. Net sales for the U.S. consumer division decreased 24.5% in the quarter to $1.28 billion, hampered by unavailable OTC drugs included in the firm's April recall of liquid pediatric products. Worldwide, consumer sales fell 10.6% year-over-year to $3.57 billion. Several bright spots in the quarter included "positive" results of the Dabao Chinese skin-care line and the launch of Listerine Zero alcohol-free mouthwash, firm says. J&J's worldwide net sales dipped 0.7% to $14.98 billion for the quarter and net earnings increased 2.2% to $3.42 billion
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS017276

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel